Zirconium: Biomedical and nephrological applications

ASAIO Journal

Volumn 56, Issue 6, 2010, Pages 550-556

  Lee, David B N ^a,b,c,d   Roberts, Martin ^a,b,c,d   Bluchel, Christian G ^d,e   Odell, Ross A ^f  

^a Laboratory for Artificial Kidney Innovation and Development (LAKID)   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AWAK Technologies Inc   (United States)

^e TEMASEK POLYTECHNIC   (Singapore)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL KIDNEY; BIOMEDICAL USE; CAUSE-AND-EFFECT RELATIONSHIPS; CLINICAL STUDY; CONTAMINATED WATER; DENTAL IMPLANTS; DESIGN AND CONSTRUCTION; HEMOFILTRATION; HIP REPLACEMENTS; INTERNAL ORGANS; LOW TOXICITY; MEDICAL LITERATURES; PERITONEAL DIALYSIS; PHOSPHORUS POLLUTION; PUBLIC HEALTH;

ARTIFICIAL ORGANS; DENTAL PROSTHESES; DIALYSIS; HIP PROSTHESES; PHOSPHORUS; TOXICITY; WASTEWATER RECLAMATION; WATER POLLUTION;

ZIRCONIUM;

BIOMATERIAL; ZIRCONIUM;

ADSORPTION; ANIMAL; HUMAN; KIDNEY FAILURE; METHODOLOGY; OSTEOMALACIA; PROSTHESES AND ORTHOSES; RENAL REPLACEMENT THERAPY; REVIEW; TISSUE DISTRIBUTION; WATER MANAGEMENT;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; OSTEOMALACIA; PROSTHESES AND IMPLANTS; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; TISSUE DISTRIBUTION; WATER PURIFICATION; ZIRCONIUM;

EID: 78349240036     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181e73f20     Document Type: Article

References (86)

1. Piconi C, Maccauro G: Zirconia as a ceramic biomaterial. Biomaterials 20:1-25, 1999.
2. Greenwood NN, Earnshaw A: Chapter 21 titanium, zirconium andhafnium, in Chemistry of the Elements. Oxford, Butterworth-Heinemann, 1997, pp. 954-975.
3. Smolik M, Jakobik-Kolon A: Determination of microamounts of hafnium in zirconium using in ductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry during their separation by ion exchange on diphonix chelating resin. Anal Chem 81: 2685-2687, 2009.
4. Ghosh S, Sharma A, Talukder G: Zirconium. An abnormal traceelement in biology. Biol Trace Elem Res 35: 247-271, 1992.
5. Schroeder HA, Balassa JJ: Abnormal trace metals in man: Zirconium. J Chronic Dis 19: 573-586, 1966.
6. Chang PP, Henegbarth EA, Lang LA: Maxillary zirconia implantfixed partial dentures opposing an acrylic resin implant fixed complete denture: A two-year clinical report. J Prosthet Dent 97: 321-330, 2007.
7. Aramouni P, Zebouni E, Tashkandi E, et al: Fracture resistance andfailure location of zirconium and metallic implant abutments. J Contemp Dent Pract 9: 41-48, 2008.
8. Vigolo P, Fonzi F: An in vitro evaluation of fit of zirconium-oxide-based ceramic four-unit fixed partial dentures, generated with three different CAD/CAM systems, before and after porcelain firing cycles and after glaze cycles. J Prosthodont 17: 621-626, 2008.
9. Uludag B, Sahin V, Ozturk O: Fabrication of zirconium primarycopings to provide retention for a mandibular telescopic overdenture: A clinical report. Int J Prosthodont 21: 509-510, 2008.
10. Tsukamoto R, Chen S, Asano T, et al: Improved wear performancewith crosslinked UHMWPE and zirconia implants in knee simulation. Acta Orthop 77: 505-511, 2006.
11. Lappalainen R, Santavirta SS: Potential of coatings in total hipreplacement. Clin Orthop Relat Res (430): 72-79, 2005.
12. Garvin KL, Hartman CW, Mangla J, et al: Wear analysis in THAutilizing oxidized zirconium and crosslinked polyethylene. Clin Orthop Relat Res 467: 141-145, 2009.
13. Schadel A, Thun G, Stork L, et al: Immunodiffusion and immunohistochemical investigations on the reactivity of oxide ceramic middle-ear implants. ORL J Otorhinolaryngol Relat Spec 55: 216-221, 1993.
14. Hisbergues M, Vendeville S, Vendeville P: Zirconia: Establishedfacts and perspectives for a biomaterial in dental implantology. J Biomed Mater Res B Appl Biomater 88: 519-529, 2009.
15. Maccauro G, Bianchino G, Sangiorgi S, et al: Development of anew zirconia-toughened alumina: Promising mechanical properties and absence of in vitro carcinogenicity. Int J Immuno-pathol Pharmacol 22: 773-779, 2009.
16. Liu H, Sun X, Yin C, et al: Removal of phosphate by mesoporousZrO. J Hazard Mater, 151: 616-622, 2008.
17. Biswas BK, Inoue K, Ghimire KN, et al: Removal and recovery ofphosphorus from water by means of adsorption onto orangewaste gel loaded with zirconium. Bioresour Technol 99: 8685-8690, 2008.
18. Pan BC, Zhang QR, Zhang WM, et al: Highly effective removal ofheavy metals by polymer-based zirconium phosphate: A case study of lead ion. J Colloid Interface Sci 310: 99-105, 2007.
19. Pan B, Pan B, Chen X, et al: Preparation and preliminary assessment of polymer-supported zirconium phosphate for selective lead removal from contaminated water. Water Res 40: 2938-2946, 2006.
20. Peng X, Luan Z, Zhang H, et al: Zirconia pillared montmorillonitefor removal of arsenate from water. J Environ Sci Health A Tox Hazard Subst Environ Eng 40: 1055-1067, 2005.
21. Um W, Mattigod S, Serne RJ, et al: Synthesis of nanoporouszirconium oxophosphate and application for removal of U(VI). Water Res 41: 3217-3226, 2007.
22. Levy E: Method of reducing contaminants in drinking water, inU.S.P.a.T. Office (ed), United States Patent Application Publication, 2003.
23. Karl DW, Magnusson JC, Carr PW, et al: Preliminary assessment of removal of pyrogenic lipopolysaccharides with colloidal zirconia adsorbents. Enzyme Microb Technol 13: 708-715, 1991.
24. Murisasco A, Baz M, Boobes Y, et al: A continuous hemofiltrationsystem using sorbents for hemofiltrate regeneration. Clin Nephrol 26(suppl 1): S53-S57, 1986.
25. Shaldon S, Beau MC, Claret G, et al: Sorbent regeneration ofultrafiltrate as a long-term treatment of end-stage renal failure. Artif Organs 2: 343-347, 1978.
26. Shapiro WB, Schilb TP, Porush JG: Sorbent recycling of ultrafiltrate in man-A 45-week crossover study. Clin Nephrol 26(suppl 1): S47-S52, 1986.
27. Hansen S: Sorbent dialysis in the third millennium. Nephrol NewsIssues 20: 43, 45, 2006.
28. Blumenkrantz MJ, Gordon A, Roberts M, et al: Applications of theRedy sorbent system to hemodialysis and peritoneal dialysis. Artif Organs 3: 230-236, 1979.
29. Murisasco A, Reynier JP, Ragon A, et al: Continuous arteriovenous hemofiltration in a wearable device to treat end-stage renal disease. ASAIO Trans 32: 567-571, 1986.
30. Davenport A, Gura V, Ronco C, et al: A wearable haemodialysisdevice for patients with end-stage renal failure: A pilot study. Lancet 370: 2005-2010, 2007.
31. Lee DB, Roberts M: A peritoneal-based automated wearable artificial kidney. Clin Exp Nephrol 12: 171-180, 2008.
32. Lande AJ, Resig PP, Avin CM, et al: Forearm worn artificial kidneydemonstrates "blood" flow modulation, "plasma" filtration and A/V pressure amplification for absorbents cartridge perfusion. J Amer Soc Nephrol 19(Abstract): 458A, 2008.
33. Ofsthun NJ, Stennett AK. An Integrated Membrane/Sorbent PDApproach to a Wearable Artificial Kidney. Paper presented at: World Congress on Medical Physics and Biomedical Engineering, International Federation of Medical and Biological Engineering (IFMBE) 2009; Munich, Germany. Editors: Dössel O, Schlegel WC, 729-732.
34. Odell GA, George CRP, Farrell PC. The transfer of zirconiumduring sorbent dialysis: Center for Biomedical Engineering, P.O. Box 1, Kensington, N.S.W. Australia 2033, . 1985. Personal Communication.
35. Rodriguez M, Felsenfeld AJ, Samara S, et al: Zirconium does notproduce osteomalacia in rats with chronic renal failure. Trans Am Soc Artif Intern Organs 31: 655-659, 1985.
36. Ahrens LH: Spectrochemical Analysis. Cambridge, MA, Addison-Welsley Press, 1950.
37. Thamer BJ, Voigt AF: Zirconium chloranilate complexes. J AmChem Soc 73: 3197-3202, 1951.
38. Bolann BJ, Rahil-Khazen R, Henriksen H, et al: Evaluation ofmethods for trace-element determination with emphasis on their usability in the clinical routine laboratory. Scand J Clin Lab Invest 67: 353-366, 2007.
39. Kunze J, Koelling S, Reich M, et al: Use of ultrasonic nebulizerwith desolvator membrane for the determination of titanium and zirconium in human serum by means of inductively coupled plasmamass spectroscopy. Fresenius J Anal Chem 366: 165-166, 2000.
40. Aono H, Araki S: Circadian rhythms in the urinary excretion ofheavy metals and organic substances in metal workers in relation to renal excretory mechanism: Profile analysis. Int Arch Occup Environ Health 60: 1-6, 1988.
41. Araki S, Aono H: Effects of water restriction and water loading ondaily urinary excretion of heavy metals and organic substances in metal workers. Br J Ind Med 46: 389-392, 1989.
42. Jarup L: Hazards of heavy metal contamination. Br Med Bull 68:167-182, 2003.
43. Sollazzo V, Palmieri A, Pezzetti F, et al: Genetic effect of zirconium oxide coating on osteoblastlike cells. J Biomed Mater Res B Appl Biomater 84:550-558, 2008.
44. Braz MG, Marcondes JP, Matsumoto MA, et al: Genotoxicity inprimary human peripheral lymphocytes after exposure to radiopacifiers in vitro. J Mater Sci Mater Med 19: 601-605, 2008.
45. Schroeder HA, Nason AP: Trace-element analysis in clinicalchemistry. Clin Chem 17: 461-474, 1971.
46. Lemiasev MF, Babushkina LG, Semenov GV, et al: [Dust andradiation factors in the manufacture of refractory materials from zirconium dioxide]. Gig Sanit 35: 38-41, 1970.
47. Uragoda CG, Pinto MR: An investigation into the health of workers in an ilmenite extracting plant. Med J Aust 1: 167-169, 1972.
48. Hadjimichael OC, Brubaker RE: Evaluation of an occupationalrespiratory exposure to a zirconium-containing dust. J Occup Med 23: 543-547, 1981.
49. Shelley WB, Hurley HJ: The allergic origin of zirconium deodorant granulomas. Br J Dermatol 70: 75-101, 1958.
50. Neuhauser I, Rubin L, Slepyan AH, et al: Granulomas of theaxillas caused by deodorants. J Am Med Assoc 162: 953-955, 1956.
51. Montemarano AD, Sau P, Johnson FB, et al: Cutaneous granulomas caused by an aluminum-zirconium complex: An ingredient of antiperspirants. J Am Acad Dermatol 37: 496-498, 1997.
52. Skelton HG III, Smith KJ, Johnson FB, et al: Zirconium granulomaresulting from an aluminum zirconium complex: A previously unrecognized agent in the development of hypersensitivity granulomas. J Am Acad Dermatol 28: 874-876, 1993.
53. Epstein WL, Allen JR: Granulomatous hypersenitivity after use of zirconium-containing poison oak lotions. JAMA 190: 940-942, 1964.
54. Williams S, Freemont AJ: Aerosol antiperspirants and axillarygranulomata. Br Med J (Clin Res Ed) 288: 1651-1652, 1984.
55. Laden K: Introduction and history of antiperspirants and deodorants, in Laden K, Felger CB (eds), Antiperspirants and Deodorants. New York, Marcel Decker, 1988, pp. 1-13.
56. Frommel D, Ayranci B, Pfeifer HR, et al: Podoconiosis in theEthiopian Rift Valley. Role of beryllium and zirconium. Trop Geogr Med 45:165-167, 1993.
57. Ham KN, Brown DJ, Dawborn JK, et al: Dialysis osteomalacia: Apossible role for zirconium as well as aluminium. Pathology 17: 458-463, 1985.
58. Mion C, Branger B, Issautier R, et al: Dialysis fracturing osteomalacia without hyperparathyroidism in patients treated with HCO3 rinsed Redy cartridge. Trans Am Soc Artif Intern Organs 27: 634-638, 1981.
59. Pierides AM, Frohnert PP: Aluminum related dialysis osteomalaciaand dementia after prolonged use of the Redy cartridge. Trans Am Soc Artif Intern Organs 27: 629-633, 1981.
60. Roberts M, Lee DBN, Ash S, Loke G, Ku G. Sorbent Dialysis andthe Wearable Kidney. In: Ing TS, Rahman MA, Kjellstrand CM, eds. Improving Dialysis: Building on Knowledge to Secure A Better Future Singapore: World Scientific Publishing Co; In Press.
61. Robertson JA, Felsenfeld AJ, Haygood CC, et al: Animal model ofaluminum-induced osteomalacia: Role of chronic renal failure. Kidney Int 23: 327-335, 1983.
62. Whited BM, Skrtic D, Love BJ, et al: Osteoblast response tozirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate. J Biomed Mater Res A 76: 596-604, 2006.
63. Sollazzo V, Pezzetti F, Scarano A, et al: Zirconium oxide coatingimproves implant osseointegration in vivo. Dent Mater 24: 357-361, 2008.
64. Palmieri A, Pezzetti F, Brunelli G, et al: Zirconium oxide regulatesRNA interfering of osteoblast-like cells. J Mater Sci Mater Med 19: 2471-2476, 2008.
65. Ramaswamy Y, Wu C, Van Hummel A, et al: The responses ofosteoblasts, osteoclasts and endothelial cells to zirconium modified calcium-silicate-based ceramic. Biomaterials 29: 4392-4402, 2008.
66. Carano RA, Filvaroff EH: Angiogenesis and bone repair. DrugDiscov Today 8: 980-989, 2003.
67. Kaigler D, Krebsbach PH, Wang Z, et al: Transplanted endothelialcells enhance orthotopic bone regeneration. J Dent Res 85: 633-637, 2006.
68. Graff L, Burnel D: Reduction of dietary phosphorus absorption byoral phoshorus binders. Res Commun Mol Pathol Pharmacol 90: 389-401, 1995.
69. Gardner DL, Emmerling DC, Williamson KD, et al: Encapsulatedadsorbents for removal of nitrogenous metabolites via oral ingestion. Kidney Int Suppl (3): 383-386, 1975.
70. Gardner DL, Falb RD, Kim BC, et al: Possible uremic detoxification via oral-ingested microcapsules. Trans Am Soc Artif Intern Organs 17: 239-245, 1971.
71. Davidson JA, Daigle KP, Kovacs P: Wear-resistant, hemocom-patible Ti-Nb-Zr and Zr-Nb alloys to improve blood pump design and performance. Artif Organs 20: 513-522, 1996.
72. Fischer H, Luk M, Oedekoven B, et al: Hemocompatibility of highstrength oxide ceramic materials: An in vitro study. J Biomed Mater Res A 81: 982-986, 2007.
73. Luo G, Tang J, He W, et al: Antibacterial effect of dressing scontaining multivalent silver ion carried by zirconium phosphate on experimental rat burn wounds. Wound Repair Regen 16: 800-804, 2008.
74. Grossner-Schreiber B, Teichmann J, Hannig M, et al: Modifiedimplant surfaces show different biofilm compositions under in vivo conditions. Clin Oral Implants Res 20: 817-826, 2009.
75. Scarano A, Piattelli M, Caputi S, et al: Bacterial adhesion oncommercially pure titanium and zirconium oxide disks: An in vivo human study. J Periodontol 75: 292-296, 2004.
76. Rimondini L, Cerroni L, Carrassi A, et al: Bacterial colonization ofzirconia ceramic surfaces: An in vitro and in vivo study. Int J Oral Maxillofac Implants 17: 793-798, 2002.
77. Schubert J. An experimental study of the effect of zirconium andsodium citrate treatment on the metabolism of plutonium and radioyttrium. J Lab Clin Med 34: 313-325, 1949.
78. Zander-Principati GE, Kuzma JF. Zirconium citrate reduces SR-90body burden. Health Phys 10: 473-477, 1964.
79. Lewis's Pharmacology. Crossland J (Ed). London: E & S; 1970, pg1124.
80. Severa J: [Zirconium hexacyanoferroate in the therapy of intravenous strontium-85 and cesium-134 lesion of the body]. Radio-biologiia 17: 629-631, 1977.
81. Allen OR, Knox RJ, McGowan PC. Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs. Dalton Trans (39): 5293-5295, 2008.
82. Wolfe EA, Chang TM: Orally ingested microencapsulated ureaseand an adsorbent, zirconium phosphate, to remove urea in kidney failure. Int J Artif Organs 10: 269-274, 1987.
83. Kjellstrand C, Borges H, Pru C, et al: On the clinical use ofmicroencapsulated zirconium phosphateurease for the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 27: 24-30, 1981.
84. Moller BB, Bahnsen M, Solgaard P, et al: Toxicological problemswith the Redy system. Scand J Urol Nephrol (suppl 30): 23-27, 1976.
85. Odell RA: Sorbent dialysis, in Nissenson AR, Fine RN, Gentile DE(eds), Clinical Dialysis. Norwalk, CT, Appleton-Century-Crofts, .1990. pp. 712-719.
86. Curtis JR, Sampson B: Aluminium kinetics during haemodialysis withthe Redy 2000 Sorbsystem. Int J Artif Organs 12: 683-687, 1989.